pelvic reconstructive surgery

From Aaushi
Jump to navigation Jump to search

Indications

* not recommended

Complications

* topical vaginal estrogen may suffice to treat symptoms of exposed vaginal mesh without surgical removal[1]

Management

More general terms

More specific terms

Additional terms

References

  1. 1.0 1.1 Geriatric Review Syllabus, 9th edition (GRS9) Medinal-Walpole A, Pacala JT, Porter JF (eds) American Geriatrics Society, 2016
    Geriatric Review Syllabus, 10th edition (GRS10) Harper GM, Lyons WL, Potter JF (eds) American Geriatrics Society, 2019
  2. Abbott S, Unger CA, Evans JM et al Evaluation and management of complications from synthetic mesh after pelvic reconstructive surgery: a multicenter study. Am J Obstet Gynecol. 2014 Feb;210(2):163.e1-8 PMID: https://www.ncbi.nlm.nih.gov/pubmed/24126300
  3. Crosby EC, Abernethy M, Berger MB et al Symptom resolution after operative management of complications from transvaginal mesh. Obstet Gynecol. 2014 Jan;123(1):134-9. PMID: https://www.ncbi.nlm.nih.gov/pubmed/24463673 Free PMC Article
  4. Ellington DR, Richter HE. The role of vaginal mesh procedures in pelvic organ prolapse surgery in view of complication risk. Obstet Gynecol Int. 2013;2013:356960. Review. PMID: https://www.ncbi.nlm.nih.gov/pubmed/24069035 Free PMC Article
  5. 5.0 5.1 Shatkin-Margolis A et al. Self-removal of a urinary catheter after urogynecologic surgery: A randomized controlled trial. Obstet Gynecol 2019 Nov; 134:1027 PMID: https://www.ncbi.nlm.nih.gov/pubmed/31599827 https://insights.ovid.com/crossref?an=00006250-201911000-00017